These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 25907167)

  • 1. Personalized medicine in diabetes mellitus: current opportunities and future prospects.
    Kleinberger JW; Pollin TI
    Ann N Y Acad Sci; 2015 Jun; 1346(1):45-56. PubMed ID: 25907167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Personalized Medicine in the Management of Diabetes Mellitus.
    Elk N; Iwuchukwu OF
    Pharmacotherapy; 2017 Sep; 37(9):1131-1149. PubMed ID: 28654165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision diabetes: a realistic outlook on a promising approach.
    Marshall SM
    Diabetologia; 2017 May; 60(5):766-768. PubMed ID: 28303304
    [No Abstract]   [Full Text] [Related]  

  • 4. Precision medicine: The future in diabetes care?
    Scheen AJ
    Diabetes Res Clin Pract; 2016 Jul; 117():12-21. PubMed ID: 27329017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision medicine for managing diabetes.
    Klonoff DC
    J Diabetes Sci Technol; 2015 Jan; 9(1):3-7. PubMed ID: 25550409
    [No Abstract]   [Full Text] [Related]  

  • 6. From Individualized to Personalized Medicine in Diabetes: An Expert Overview.
    Mohan V; Das AK; Mukherjee JJ; Seshadri K; Jha S; Kalra S
    J Assoc Physicians India; 2019 Sep; 67(9):78-82. PubMed ID: 31561694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
    Florez JC
    Diabetologia; 2017 May; 60(5):800-807. PubMed ID: 28283684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical worthlessness of genetic prediction of common forms of diabetes mellitus and related chronic complications: A position statement of the Italian Society of Diabetology.
    Buzzetti R; Prudente S; Copetti M; Dauriz M; Zampetti S; Garofolo M; Penno G; Trischitta V
    Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):99-114. PubMed ID: 28063875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in diabetes genetics].
    Njølstad PR; Hertel JK; Søvik O; Raeder H; Johansson S; Molven A
    Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1145-9. PubMed ID: 20531501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Importance of Precision Medicine in Type 2 Diabetes Mellitus (T2DM): From Pharmacogenetic and Pharmacoepigenetic Aspects.
    Khatami F; Mohajeri-Tehrani MR; Tavangar SM
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):719-731. PubMed ID: 31122183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized medicine in diabetes.
    Malandrino N; Smith RJ
    Clin Chem; 2011 Feb; 57(2):231-40. PubMed ID: 21127150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision Diabetes Is Slowly Becoming a Reality.
    Mohan V; Radha V
    Med Princ Pract; 2019; 28(1):1-9. PubMed ID: 30685765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacogenetics of oral antidiabetic treatment].
    Tkáč I
    Vnitr Lek; 2016 Mar; 62(3):186-8. PubMed ID: 27180666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope.
    Aghaei Meybodi HR; Hasanzad M; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):166-174. PubMed ID: 28282717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Pathogenesis, Therapeutic Targets/Drug Action and Pharmacogenetics of Type 2 Diabetes: Is there a Future for Personalised Medicine?
    Engwa GA; Nweke FN; Karngong GN; Afiukwa CA; Nwagu KE
    Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1569-1589. PubMed ID: 32334506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine in the management of type 2 diabetes.
    Gloyn AL; Drucker DJ
    Lancet Diabetes Endocrinol; 2018 Nov; 6(11):891-900. PubMed ID: 29699867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monogenic Diabetes: Genetics and Relevance on Diabetes Mellitus Personalized Medicine.
    Sousa M; Bruges-Armas J
    Curr Diabetes Rev; 2020; 16(8):807-819. PubMed ID: 31886753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical consequences of heterogeneity within and between different diabetes types.
    Redondo MJ; Hagopian WA; Oram R; Steck AK; Vehik K; Weedon M; Balasubramanyam A; Dabelea D
    Diabetologia; 2020 Oct; 63(10):2040-2048. PubMed ID: 32894314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics and personalized treatment of type 2 diabetes.
    Semiz S; Dujic T; Causevic A
    Biochem Med (Zagreb); 2013; 23(2):154-71. PubMed ID: 23894862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in diabetes: influence on therapy with oral antidiabetics.
    Glamočlija U; Jevrić-Čaušević A
    Acta Pharm; 2010 Dec; 60(4):387-406. PubMed ID: 21169132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.